Skip to content

Prospective study on photodynamic therapy for synovial hyperplasia in patients with refractory rheumatoid arthritis

Prospective study on photodynamic therapy for synovial hyperplasia in patients with refractory rheumatoid arthritis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014918
Enrollment
Unknown
Registered
2018-02-21
Start date
2018-08-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Rheumatoid Arthritis

Interventions

Traditional treatment group:Basic treatment+NS+laser radiation
PDT once group:Basic treatment+photosensitizer+laser radiation for one time
PDT twice group:treatment+photosensitizer+laser radiation for two times

Sponsors

Integrated Hospital of Traditional Chinese Medicine, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Male or female pts (aged between 18 and 70 years) ; 2. Patients who meet the diagnostic criteria for RRA; 3. Patients with at least one side knee swelling for one month; 4. Patients with synovial hyperplasia confirmed by ultrasound or MRI: UCSS more than 2 points and/or single-site MR scores more than 2 points; 5. Patients capable of signing the informed consent and able to complete the experiment as required; 6. Patients with good compliance and who will complete follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with serious primary diseases such as those affecting the cardiovascular, liver, kidney, brain or haematopoietic system; 2. Patients with infection and abnormal coagulation function; 3. Breast-feeding and pregnant women; 4. Patients allergic to anaesthetics and photosensitive drugs; 5. Patients injected with intra-articular drug in one month; 6. Patients with arthritic knee joints with osteotropic ankylosis indicated by X-ray.

Design outcomes

Primary

MeasureTime frame
The Ultrasound Compound Score of Synovitis;

Secondary

MeasureTime frame
DAS28 score;RF;Anti CCP antibody;ESR;CRP;Histopathological evaluation;Joint X-ray;Clinical evaluation of knee joint;

Countries

China

Contacts

Public ContactChanghong Xiao

Integrated Hospital of Traditional Chinese Medicine, Southern Medical University

nfzxyfsbk@163.com+86 13189098313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026